Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-01-25 @ 7:39 PM
Study NCT ID:
NCT04991350
Status:
TERMINATED
Last Update Posted:
2023-02-16
First Post:
2021-07-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema
Sponsor:
Cairo University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CU372021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None